SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001664710-20-000050
Filing Date
2020-11-10
Accepted
2020-11-10 16:20:36
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kros-20200930.htm   iXBRL 10-Q 1626456
2 EX-31.1 exhibit311q32020.htm EX-31.1 16139
3 EX-31.2 exhibit312q32020.htm EX-31.2 16020
4 EX-32.1 exhibit321q32020.htm EX-32.1 9934
10 kros-20200930_g1.jpg GRAPHIC 500448
11 kros-20200930_g2.jpg GRAPHIC 335870
  Complete submission text file 0001664710-20-000050.txt   7838643

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kros-20200930.xsd EX-101.SCH 34049
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kros-20200930_cal.xml EX-101.CAL 60879
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kros-20200930_def.xml EX-101.DEF 204359
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kros-20200930_lab.xml EX-101.LAB 444454
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kros-20200930_pre.xml EX-101.PRE 323409
12 EXTRACTED XBRL INSTANCE DOCUMENT kros-20200930_htm.xml XML 780936
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39264 | Film No.: 201301387
SIC: 2834 Pharmaceutical Preparations